These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 9444947

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
    Morabito F, Stelitano C, Callea I, Filangeri M, Oliva B, Sculli G, Callea V, Nobile F, Brugiatelli M.
    Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527
    [Abstract] [Full Text] [Related]

  • 4. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM, Katato K, Almatchy VP, Wall N, Liu KZ, Schultz CP, Mantsch HH, Varterasian M, al-Katib AM.
    Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro.
    Begleiter A, Verburg L, Ashique A, Lee K, Israels LG, Mowat MR, Johnston JB.
    Leukemia; 1995 Nov; 9(11):1875-81. PubMed ID: 7475278
    [Abstract] [Full Text] [Related]

  • 8. Chlorambucil in chronic lymphocytic leukemia: mechanism of action.
    Begleiter A, Mowat M, Israels LG, Johnston JB.
    Leuk Lymphoma; 1996 Oct; 23(3-4):187-201. PubMed ID: 9031099
    [Abstract] [Full Text] [Related]

  • 9. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs.
    Silber R, Degar B, Costin D, Newcomb EW, Mani M, Rosenberg CR, Morse L, Drygas JC, Canellakis ZN, Potmesil M.
    Blood; 1994 Nov 15; 84(10):3440-6. PubMed ID: 7949099
    [Abstract] [Full Text] [Related]

  • 10. Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukemia.
    Bosanquet AG, Bell PB.
    Blood; 1996 Mar 01; 87(5):1962-71. PubMed ID: 8634445
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia.
    Tefferi A, Levitt R, Li CY, Schroeder G, Tschetter LK, Michalak JC, Krook JE, Witzig TE.
    Am J Clin Oncol; 1999 Oct 01; 22(5):509-16. PubMed ID: 10521069
    [Abstract] [Full Text] [Related]

  • 12. Similarities between the sensitivity to 2-chlorodeoxyadenosine of lymphocytes from CLL patients and bryostatin 1-treated WSU-CLL cells: an infrared spectroscopic study.
    Liu KZ, Schultz CP, Mohammad RM, Al-Katib AM, Johnston JB, Mantsch HH.
    Cancer Lett; 1998 May 15; 127(1-2):185-93. PubMed ID: 9619876
    [Abstract] [Full Text] [Related]

  • 13. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
    Johnston JB, Paul JT, Neufeld NJ, Haney N, Kropp DM, Hu X, Cheang M, Gibson SB.
    Leuk Lymphoma; 2004 Oct 15; 45(10):2017-27. PubMed ID: 15370246
    [Abstract] [Full Text] [Related]

  • 14. Modulation of purine analogs- and chlorambucil-induced cytotoxicity by alpha-interferon and interleukin-2 in chronic lymphocytic leukemia.
    Morabito F, Callea I, Rodinò A, Messina G, Callea V, Iacopino P, Nobile F, Brugiatelli M.
    Leukemia; 1995 Sep 15; 9(9):1450-5. PubMed ID: 7658711
    [Abstract] [Full Text] [Related]

  • 15. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
    Ganeshaguru K, Wickremasinghe RG, Jones DT, Gordon M, Hart SM, Virchis AE, Prentice HG, Hoffbrand AV, Man A, Champain K, Csermak K, Mehta AB.
    Haematologica; 2002 Feb 15; 87(2):167-76. PubMed ID: 11836167
    [Abstract] [Full Text] [Related]

  • 16. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
    Bosanquet AG, Sturm I, Wieder T, Essmann F, Bosanquet MI, Head DJ, Dörken B, Daniel PT.
    Leukemia; 2002 Jun 15; 16(6):1035-44. PubMed ID: 12040435
    [Abstract] [Full Text] [Related]

  • 17. Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?
    Robak T, Błoński JZ, Kasznicki M.
    Leuk Lymphoma; 2001 May 15; 41(5-6):545-57. PubMed ID: 11378572
    [Abstract] [Full Text] [Related]

  • 18. Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.
    Robak T, Bloński JZ, Kasznicki M, Blasińska-Morawiec M, Krykowski E, Dmoszyńska A, Mrugala-Spiewak H, Skotnicki AB, Nowak W, Konopka L, Ceglarek B, Maj S, Dwilewicz-Trojaczek J, Hellmann A, Urasiński I, Zdziarska B, Kotlarek-Haus S, Potoczek S, Grieb P.
    Blood; 2000 Oct 15; 96(8):2723-9. PubMed ID: 11023504
    [Abstract] [Full Text] [Related]

  • 19. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
    Lotfi K, Månsson E, Spasokoukotskaja T, Pettersson B, Liliemark J, Peterson C, Eriksson S, Albertioni F.
    Clin Cancer Res; 1999 Sep 15; 5(9):2438-44. PubMed ID: 10499616
    [Abstract] [Full Text] [Related]

  • 20. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J, McQuillan A, Aubin R, Alaoui-Jamali M, Batist G, Christodoulopoulos G, Panasci LC.
    Mutat Res; 1995 May 15; 336(3):269-78. PubMed ID: 7739615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.